RxDoctor Payments Data

Cuixia Tian

Neurology with Special Qualifications in Child Neurology · Cincinnati, OHNPI 1649414533

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $54,873 of the $90,727 with a category attached, or 60.5%. 10 manufacturers reported payments, led by Sarepta Therapeutics, Inc. at 40.3% of the total. Among neurology with special qualifications in child neurology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$90,727in general payments, 2019–2025

Across 103 payments — averaging $880.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sarepta Therapeutics, Inc.$37K
  • Biogen$23K
  • Catalyst Pharmaceuticals, Inc.$13K
  • Pfizer$9K
  • ITF Therapeutics LLC$6K
  • F. Hoffmann-la Roche AG$2K
  • plus $2K from 4 others
$1,148,524in research payments, 2019–2025

Across 146 payments — averaging $7866.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Products Limited$448K
  • PTC Therapeutics, Inc.$257K
  • Sarepta Therapeutics, Inc.$148K
  • Pfizer$126K
  • Hoffmann-la Roche Limited$86K
  • Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$38K
  • plus $45K from 2 others

What the payments were for

  • Consulting fees$54,87360%
  • Speaking & faculty fees$21,90224%
  • Travel & lodging$10,01111%
  • Food & beverage$3,8204%
  • Education$1210%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$90,727 in reported general payments places this provider in the 95th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
EmflazaDeflazacort13$224,564

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PTC Therapeutics, Inc.Emflaza$334$224,56413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

Other neurology with special qualifications in child neurology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →